Wexford Science (Life Science and Medical Real Assets) is Buildings and Property in United States that focus on Life science business. They cover business area such as life science, medical real estate asset, revenue, tenant, investment grade company, public company, an equity market capitalization, two development asset, Duke University, Wake Forest University.
-
Life Science
-
Baltimore, MD
United States
Private
life sciencemedical real estate assetrevenuetenantinvestment grade companypublic companyan equity market capitalizationtwo development assetDuke UniversityWake Forest University
* We use standard office opening hours in near Wexford Science (Life Science and Medical Real Assets)'s location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
Wexford Science (Life Science And Medical Real Assets) is Buildings and Property business from United States that founded in - ( years old in ), Wexford Science (Life Science and Medical Real Assets) business is focusing on Life Science.
Wexford Science (Life Science and Medical Real Assets) headquarter office and corporate office address is located in Baltimore, MD United States.
Wexford Science (Life Science and Medical Real Assets) was founded in United States.
In , Wexford Science (Life Science and Medical Real Assets) is currently focus on Life science sector.
Above is snippet of Google Trends for "Life science" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with Wexford Science (Life Science and Medical Real Assets), any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
